Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome

Clinical trial NCT01511978 · COMPLETED

Trial details

NCT number: NCT01511978
Sponsor: Jacobus Pharmaceutical
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lambert-Eaton Myasthenic Syndrome Eaton-Lambert Myasthenic Syndrome

Start date: 2012-01-01
Primary completion: 2014-02-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.